Erstad, Derek J.
Robinson, Kristen A.
Beaty, Karen
Rafeeq, Safia
Chiang, Yi-Ju
Raghav, Kanwal
Shen, John P.
Overman, Michael J.
Foo, Wai Chin
Taggart, Melissa W.
Mansfield, Paul. F.
Royal, Richard E.
Fournier, Keith F.
Scally, Christopher P.
Funding for this research was provided by:
National Cancer Institute (L30 CA171000)
Cancer Prevention and Research Institute of Texas (RR180035)
Cancer Center Support Grant (P30 CA016672)
Sun and Do Lee GI Research and Care Fund
Dwyer Endowment for Surgical Oncology
Schroeder Family Appendiceal Cancer Research Fund
Bidnick Family Appendiceal Cancer Research Fund
William Payne Family Appendiceal Cancer Research Fund
Conrad Family Appendiceal Cancer Research Fund
Article History
Received: 9 July 2022
Accepted: 15 October 2022
First Online: 28 February 2023
Declarations
:
: This retrospective study was reviewed and approved by the MD Anderson Cancer Center Institutional Review Board prior to initiation.
: All patients included in this study provided signed consent for inclusion of their health information into a prospective clinical database maintained at the University of Texas MD Anderson Cancer Center. Consent includes publication of deidentified information for studies derived from this prospective database. All patient information for this study was derived from this database and has been deindentified.
: The authors declare no competing interests.